Gut‐lung axis and asthma: A historical review on mechanism and future perspective
Clinical and Translational Allergy · 2024-05 · 14 (5)
DOI: 10.1002/clt2.12356 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Allergy, online erschienen am 30.04.2024. Verfasst von Xiu-Ling Song und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Natural Science Foundation of China, Scientific Research Start-up Fund for High-level Talents of Affiliated Hospital of Guangdong Medical University.
Abstract (Originalsprache)
Background
Gut microbiota are closely related to the development and regulation of the host immune system by regulating the maturation of immune cells and the resistance to pathogens, which affects the host immunity. Early use of antibiotics disrupts the homeostasis of gut microbiota and increases the risk of asthma. Gut microbiota actively interact with the host immune system via the gut‐lung axis, a bidirectional communication pathway between the gut and lung. The manipulation of gut microbiota through probiotics, helminth therapy, and fecal microbiota transplantation (FMT) to combat asthma has become a hot research topic. Body This review mainly describes the current immune pathogenesis of asthma, gut microbiota and the role of the gut‐lung axis in asthma. Moreover, the potential of manipulating the gut microbiota and its metabolites as a treatment strategy for asthma has been discussed.
Conclusion
The gut‐lung axis has a bidirectional effect on asthma. Gut microecology imbalance contributes to asthma through bacterial structural components and metabolites. Asthma, in turn, can also cause intestinal damage through inflammation throughout the body. The manipulation of gut microbiota through probiotics, helminth therapy, and FMT can inform the treatment strategies for asthma by regulating the maturation of immune cells and the resistance to pathogens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
ORCID-Profile: Wen Li
Förderung
- National Natural Science Foundation of China
- Guangdong Natural Science Foundation of China
- Scientific Research Start-up Fund for High-level Talents of Affiliated Hospital of Guangdong Medical University
Zitieren
APA
Song, X. L., Liang, J., Lin, S. Z., Xie, Y. W., Ke, C. H., Ao, D., Lu, J., Chen, X. M., He, Y. Z., Liu, X. H., & Li, W. (2024). Gut‐lung axis and asthma: A historical review on mechanism and future perspective. Clinical and Translational Allergy, 14(5). https://doi.org/10.1002/clt2.12356
Vancouver
Song XL, Liang J, Lin SZ, Xie YW, Ke CH, Ao D, et al. Gut‐lung axis and asthma: A historical review on mechanism and future perspective. Clinical and Translational Allergy. 2024;14(5). doi:10.1002/clt2.12356
BibTeX
@article{Song2024,
author = {Song, Xiu-Ling and Liang, Juan and Lin, Shao-Zhu and Xie, Yu-Wei and Ke, Chuang-Hong and Ao, Dang and Lu, Jun and Chen, Xue-Mei and He, Ying-Zhi and Liu, Xiao-Hua and Li, Wen},
title = {Gut‐lung axis and asthma: A historical review on mechanism and future perspective},
journal = {Clinical and Translational Allergy},
year = {2024},
volume = {14},
number = {5},
doi = {10.1002/clt2.12356}
}
EUVIMED